vs

Side-by-side financial comparison of Star Holdings (STHO) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.

Star Holdings is the larger business by last-quarter revenue ($25.4M vs $20.6M, roughly 1.2× Entrada Therapeutics, Inc.). Star Holdings runs the higher net margin — -75.5% vs -84.4%, a 8.9% gap on every dollar of revenue. On growth, Star Holdings posted the faster year-over-year revenue change (-22.6% vs -65.2%). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -0.2%).

Blue Star Ltd is an Indian multinational home appliances company, headquartered in Mumbai. It specializes in air conditioning, commercial refrigeration and MEP. It is the country's second largest homegrown player in the air conditioning space.

Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.

STHO vs TRDA — Head-to-Head

Bigger by revenue
STHO
STHO
1.2× larger
STHO
$25.4M
$20.6M
TRDA
Growing faster (revenue YoY)
STHO
STHO
+42.6% gap
STHO
-22.6%
-65.2%
TRDA
Higher net margin
STHO
STHO
8.9% more per $
STHO
-75.5%
-84.4%
TRDA
Faster 2-yr revenue CAGR
TRDA
TRDA
Annualised
TRDA
6.4%
-0.2%
STHO

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
STHO
STHO
TRDA
TRDA
Revenue
$25.4M
$20.6M
Net Profit
$-19.1M
$-17.3M
Gross Margin
Operating Margin
-91.7%
-106.0%
Net Margin
-75.5%
-84.4%
Revenue YoY
-22.6%
-65.2%
Net Profit YoY
81.3%
-173.8%
EPS (diluted)
$-1.52
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STHO
STHO
TRDA
TRDA
Q4 25
$25.4M
Q3 25
$28.1M
Q2 25
$42.1M
Q1 25
$14.6M
$20.6M
Q4 24
$32.8M
$37.4M
Q3 24
$24.6M
$19.6M
Q2 24
$30.6M
$94.7M
Q1 24
$25.4M
$59.1M
Net Profit
STHO
STHO
TRDA
TRDA
Q4 25
$-19.1M
Q3 25
$1.8M
Q2 25
$-39.3M
Q1 25
$-7.6M
$-17.3M
Q4 24
$-102.6M
$1.1M
Q3 24
$91.9M
$-14.0M
Q2 24
$-27.1M
$55.0M
Q1 24
$-49.0M
$23.5M
Operating Margin
STHO
STHO
TRDA
TRDA
Q4 25
-91.7%
Q3 25
1.0%
Q2 25
-94.5%
Q1 25
-55.0%
-106.0%
Q4 24
-314.1%
-15.7%
Q3 24
-110.7%
Q2 24
-91.5%
56.4%
Q1 24
-192.6%
35.7%
Net Margin
STHO
STHO
TRDA
TRDA
Q4 25
-75.5%
Q3 25
6.4%
Q2 25
-93.5%
Q1 25
-52.0%
-84.4%
Q4 24
-313.1%
3.0%
Q3 24
374.3%
-71.7%
Q2 24
-88.8%
58.1%
Q1 24
-192.6%
39.7%
EPS (diluted)
STHO
STHO
TRDA
TRDA
Q4 25
$-1.52
Q3 25
$0.14
Q2 25
$-2.95
Q1 25
$-0.57
$-0.42
Q4 24
$-7.69
$-0.20
Q3 24
$6.90
$-0.35
Q2 24
$-2.04
$1.55
Q1 24
$-3.68
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STHO
STHO
TRDA
TRDA
Cash + ST InvestmentsLiquidity on hand
$50.1M
$67.8M
Total DebtLower is stronger
$268.7M
Stockholders' EquityBook value
$251.8M
$417.3M
Total Assets
$570.2M
$486.5M
Debt / EquityLower = less leverage
1.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STHO
STHO
TRDA
TRDA
Q4 25
$50.1M
Q3 25
$40.6M
Q2 25
$44.2M
Q1 25
$30.3M
$67.8M
Q4 24
$35.0M
$101.2M
Q3 24
$45.0M
$78.0M
Q2 24
$48.3M
$185.3M
Q1 24
$45.7M
$68.4M
Total Debt
STHO
STHO
TRDA
TRDA
Q4 25
$268.7M
Q3 25
$259.3M
Q2 25
$245.4M
Q1 25
$231.5M
Q4 24
$217.3M
Q3 24
$201.2M
Q2 24
$197.2M
Q1 24
$195.0M
Stockholders' Equity
STHO
STHO
TRDA
TRDA
Q4 25
$251.8M
Q3 25
$275.4M
Q2 25
$276.1M
Q1 25
$316.1M
$417.3M
Q4 24
$324.3M
$428.7M
Q3 24
$427.5M
$422.4M
Q2 24
$335.3M
$429.9M
Q1 24
$362.4M
$269.4M
Total Assets
STHO
STHO
TRDA
TRDA
Q4 25
$570.2M
Q3 25
$595.9M
Q2 25
$589.9M
Q1 25
$618.2M
$486.5M
Q4 24
$608.7M
$526.3M
Q3 24
$696.5M
$554.6M
Q2 24
$601.0M
$582.0M
Q1 24
$622.9M
$510.8M
Debt / Equity
STHO
STHO
TRDA
TRDA
Q4 25
1.07×
Q3 25
0.94×
Q2 25
0.89×
Q1 25
0.73×
Q4 24
0.67×
Q3 24
0.47×
Q2 24
0.59×
Q1 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STHO
STHO
TRDA
TRDA
Operating Cash FlowLast quarter
$-11.7M
$-38.5M
Free Cash FlowOCF − Capex
$-39.7M
FCF MarginFCF / Revenue
-192.9%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STHO
STHO
TRDA
TRDA
Q4 25
$-11.7M
Q3 25
$5.3M
Q2 25
$-2.6M
Q1 25
$-6.3M
$-38.5M
Q4 24
$-31.3M
$-31.6M
Q3 24
$-3.8M
$-24.3M
Q2 24
$-6.4M
$39.8M
Q1 24
$-14.2M
$-25.5M
Free Cash Flow
STHO
STHO
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
$-39.7M
Q4 24
$-32.2M
Q3 24
$-24.9M
Q2 24
$38.8M
Q1 24
$-26.4M
FCF Margin
STHO
STHO
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
-192.9%
Q4 24
-86.2%
Q3 24
-127.3%
Q2 24
41.0%
Q1 24
-44.6%
Capex Intensity
STHO
STHO
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
5.6%
Q4 24
1.7%
Q3 24
3.3%
Q2 24
1.1%
Q1 24
1.4%
Cash Conversion
STHO
STHO
TRDA
TRDA
Q4 25
Q3 25
2.95×
Q2 25
Q1 25
Q4 24
-27.94×
Q3 24
-0.04×
Q2 24
0.72×
Q1 24
-1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STHO
STHO

Land Development$13.0M51%
Other Income Revenue$9.3M37%
Operating Lease Income$2.0M8%
Other$1.2M5%

TRDA
TRDA

Segment breakdown not available.

Related Comparisons